On ECHEMI
Home > Drugs > N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide Registered Holders
N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide structure

N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide structure

N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide

Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis).

Find 5 Related Holders

MAITHRI DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
MICRO LABS LTD
United States United States

API Registration Country

API Active
Nantong Chanyoo Pharmatech Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2011-05-19
  • Country:

    China China
  • Address:

    Yangkou Chemical Industrial Park, Rudong Coastal Economic Development Zone
  • Tax NO.:

    9132062357537648XH
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

MOEHS IBERICA SL
United States United States

API Registration Country

API Active
Changzhou Pharmaceutical Factory
United States United States

API Registration Country

API Active
Recommended Suppliers of N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide
View 24 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.